PT Soho Global Health Tbk (ISX:SOHO) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SOHO PT Soho Global Health Tbk ISX:SOHO
85 GF Score
Price Rp1,205.00
GF Value Rp805.04
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is PT Soho Global Health Tbk Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


PT Soho Global Health Tbk Valuation Rank Related Terms

ISX:SOHO
85GF Score
PT Soho Global Health Tbk ISX:SOHO
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?

Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued. The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04. GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.

Key valuation signals for ISX:SOHO:

  • Valuation Rank:
  • GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Soho Global Health Tbk Business Description

Address Jalan Rawa Sumur II Kav BB No. 3, Kawasan Industri Pulogadung, Kel., Jatinegara, Kec. Cakung, Jakarta Timur, Jakarta, IDN, 13930
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
85GF Score

Get the complete analysis for ISX:SOHO

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,205.00
Price
Rp805.04
GF Value